Dr. Reddy's Laboratories Limited

Informe acción NSEI:DRREDDY

Capitalización de mercado: ₹1.1t

Dividendos de Dr. Reddy's Laboratories

Dividendo controles de criterios 5/6

Dr. Reddy's Laboratories es una empresa que paga dividendos con una rentabilidad actual de 0.67% que está bien cubierta por los beneficios.

Información clave

0.6%

Rentabilidad por dividendo

13%

Ratio de pago

Rentabilidad media de la industria0.7%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Beneficios por acción₹313.51
Rentabilidad por dividendo prevista a 3 años0.7%

Últimas actualizaciones de dividendos

Recent updates

With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

May 06
With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Apr 18
There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 02
Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Jan 19
Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Jan 01
Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

Oct 21
Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Oct 03
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Jul 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Jun 24
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Jun 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

May 27
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

May 13
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Apr 11
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

Jan 10
These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dec 05
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?

Sep 28
Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?

Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?

Aug 17
Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate

Jul 21
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00

Jul 08
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jun 22
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Larger Dividend Than Last Year At ₹30.00

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00

Jun 07
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

May 24
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Los dividendos por acción de DRREDDY se han mantenido estables en los últimos 10 años.

Dividendo creciente: El pago de dividendos de DRREDDY ha aumentado en los últimos 10 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Dr. Reddy's Laboratories vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de DRREDDY con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (DRREDDY)0.6%
Suelo de mercado 25% (IN)0.3%
Techo de mercado 25% (IN)1.2%
Media de la industria (Pharmaceuticals)0.7%
Previsión de analistas en 3 años (DRREDDY)0.7%

Dividendo destacado: El dividendo de DRREDDY(0.67%) es más alto que el 25% inferior de los pagadores de dividendos del mercado Indian (0.27%).

Alto dividendo: El (0.67%) del dividendo de DRREDDY es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Indian (1.22%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su bajo ratio de pago (12.7%), los pagos de dividendos de DRREDDY están totalmente cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Con su bajo ratio de pago en efectivo (23.2%), los pagos de dividendos de DRREDDY están bien cubiertos por los flujos de caja.


Discover strong dividend paying companies